These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The natural history of type I (severe) spinal muscular atrophy. Thomas NH; Dubowitz V Neuromuscul Disord; 1994; 4(5-6):497-502. PubMed ID: 7881295 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and histochemical findings in spinal muscular atrophy]. Fukunaga H; Moritoyo T; Okubo R; Higuchi I; Osame M No To Shinkei; 1992 Jun; 44(6):547-52. PubMed ID: 1389561 [TBL] [Abstract][Full Text] [Related]
10. Spinal muscular atrophy (SMA) type I (Werdnig-Hoffmann disease). Audic F; Barnerias C Arch Pediatr; 2020 Dec; 27(7S):7S15-7S17. PubMed ID: 33357591 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of three subtypes of spinal muscular atrophy in children. Yuan P; Jiang L Brain Dev; 2015 May; 37(5):537-41. PubMed ID: 25199871 [TBL] [Abstract][Full Text] [Related]
12. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. Zerres K; Rudnik-Schöneborn S; Forrest E; Lusakowska A; Borkowska J; Hausmanowa-Petrusewicz I J Neurol Sci; 1997 Feb; 146(1):67-72. PubMed ID: 9077498 [TBL] [Abstract][Full Text] [Related]
13. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Zerres K; Rudnik-Schöneborn S Arch Neurol; 1995 May; 52(5):518-23. PubMed ID: 7733848 [TBL] [Abstract][Full Text] [Related]
14. Migrating atelectasis in Werdnig-Hoffmann disease: pulmonary manifestations in two cases of spinal muscular atrophy type 1. Leistikow EA; Jones NE; Josephson KD; de Sierra TM; Costakos DT; Sprague D; Gorch DH; Asonye UO Pediatr Pulmonol; 1999 Aug; 28(2):149-53. PubMed ID: 10423316 [TBL] [Abstract][Full Text] [Related]
15. [Neonatal muscular spinal atrophy: a case report]. Pavone P; Velardita M; Trigilia T; Luca G; Lucenti C; Romeo G; Falsaperla R Pediatr Med Chir; 2004; 26(2):139-41. PubMed ID: 15700740 [TBL] [Abstract][Full Text] [Related]
16. Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype. Dubowitz V Eur J Paediatr Neurol; 1999; 3(2):49-51. PubMed ID: 10700538 [TBL] [Abstract][Full Text] [Related]
17. Survival probabilities of patients with childhood spinal muscle atrophy. Mannaa MM; Kalra M; Wong B; Cohen AP; Amin RS J Clin Neuromuscul Dis; 2009 Mar; 10(3):85-9. PubMed ID: 19258855 [TBL] [Abstract][Full Text] [Related]
18. Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Gilliam TC; Brzustowicz LM; Castilla LH; Lehner T; Penchaszadeh GK; Daniels RJ; Byth BC; Knowles J; Hislop JE; Shapira Y Nature; 1990 Jun; 345(6278):823-5. PubMed ID: 1972783 [TBL] [Abstract][Full Text] [Related]
19. Expression of developmentally regulated cytoskeleton and cell surface proteins in childhood spinal muscular atrophies. Soubrouillard C; Pellissier JF; Lepidi H; Mancini J; Rougon G; Figarella-Branger D J Neurol Sci; 1995 Nov; 133(1-2):155-63. PubMed ID: 8583219 [TBL] [Abstract][Full Text] [Related]
20. Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema. Russman BS; Iannacone ST; Buncher CR; Samaha FJ; White M; Perkins B; Zimmerman L; Smith C; Burhans K; Barker L J Child Neurol; 1992 Oct; 7(4):347-53. PubMed ID: 1469240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]